Securities Daily Online News: On February 26, Senxuan Pharmaceutical released the 2025 annual performance forecast, stating that the company is expected to achieve operating revenue of 552,577,290.50 yuan in 2025, a year-on-year increase of 2.87%; net profit attributable to shareholders of the listed company is projected to be 131,575,798.33 yuan, a year-on-year increase of 6.32%.
(Editor: Ren Shibi)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Senxuan Pharmaceuticals: 2025 Annual Performance Briefing Announcement
Securities Daily Online News: On February 26, Senxuan Pharmaceutical released the 2025 annual performance forecast, stating that the company is expected to achieve operating revenue of 552,577,290.50 yuan in 2025, a year-on-year increase of 2.87%; net profit attributable to shareholders of the listed company is projected to be 131,575,798.33 yuan, a year-on-year increase of 6.32%.
(Editor: Ren Shibi)